Anticorps Polyclonal de lapin anti-Prothymosin Alpha
Prothymosin Alpha Polyclonal Antibody for IHC, Indirect ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat
Applications
IHC, Indirect ELISA
Conjugaison
Non conjugué
N° de cat : 10480-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
10480-1-PBS cible Prothymosin Alpha dans les applications de IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat
| Réactivité | Humain, rat |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | Prothymosin Alpha Protéine recombinante Ag0732 |
| Nom complet | prothymosin, alpha |
| Masse moléculaire calculée | 12 kDa |
| Numéro d’acquisition GenBank | BC003510 |
| Symbole du gène | Prothymosin Alpha/PTMA |
| Identification du gène (NCBI) | 5757 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
Prothymosin alpha (PTMA) is a nuclear protein possessing a number of cellular functions including cell survival. PTMA is identified to be localized in the nuclei of neurons, while it is found in both nuclei and cytoplasm in the astrocytes and microglia of adult brai. PTMA inhibits the neuronal necrosis induced by serum-free starvation or ischemia-reperfusion stress, which causes a rapid internalization of GLUT1/4, leading a decrease in glucose uptake and cellular ATP levels. Extensive research on PTMA showed that it is of clinical significance and potential medical use as they may serve as a molecular marker for cancer prognosis and/or as therapeutic agents for treating immunodeficiencies, autoimmune diseases and malignancies.







